Septerna (SEPN) Cash & Equivalents (2023 - 2026)
Septerna's (SEPN) quarterly Cash & Equivalents came in at $71.6 million in Q1 2026, down 65.91% year-on-year from $210.0 million in Q1 2025, and down 40.69% quarter-over-quarter from $120.7 million in Q4 2025.
Septerna (SEPN) Cash & Equivalents (2023 - 2026) Analysis & Trends
Septerna's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $71.6 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 65.91% year-over-year to $71.6 million in Q1 2026; TTM through Mar 2026 was $71.6 million, a 65.91% decrease from a year earlier, with the FY2025 full-year figure at $120.7 million, down 49.32% from the prior year.
- Cash & Equivalents eased to $71.6 million in Q1 2026 per SEPN's latest filing, from $120.7 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $320.0 million in Q3 2025 and bottomed at $71.6 million in Q1 2026.
- The 4-year median for Cash & Equivalents is $120.7 million (2025), against an average of $148.9 million.
- Across the five-year window, Cash & Equivalents jumped 262.63% in 2025 and tumbled 65.91% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $88.5 million in 2023, then jumped by 169.2% to $238.2 million in 2024, then sank by 49.32% to $120.7 million in 2025, then plunged by 40.69% to $71.6 million in 2026.
- Per Business Quant, the three latest SEPN Cash & Equivalents figures stand at $71.6 million (Q1 2026), $120.7 million (Q4 2025), and $320.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 71.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.61 Mn |
| Dec 31, 2025 | 120.72 Mn |
| Sep 30, 2025 | 319.99 Mn |
| Jun 30, 2025 | 189.31 Mn |
| Mar 31, 2025 | 210.05 Mn |
| Dec 31, 2024 | 238.20 Mn |
| Sep 30, 2024 | 88.24 Mn |
| Jun 30, 2024 | 131.17 Mn |
| Mar 31, 2024 | 81.34 Mn |
| Dec 31, 2023 | 88.48 Mn |
| Sep 30, 2023 | 98.52 Mn |